What Has Been the Progress and Growth of the Medical Irradiation Market in Recent Years?
The medical irradiation market has seen considerable growth due to a variety of factors.
• The size of the medical irradiation market has seen a swift expansion in the past few years. A growth from $1.69 billion in 2024 to $1.97 billion in 2025 at a Compound Annual Growth Rate (CAGR) of 16.7% is expected. Factors contributing to the growth in the preceding period include an increase in cancer cases, the growing preference for radiation therapy, a rising elderly population, a surge in demand for non-invasive treatments, and the development of healthcare infrastructure.
What Is The Expected Growth In The Medical Irradiation Market Size Evolve over the Forecast Period?
The medical irradiation market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, a rapid growth is anticipated in the medical irradiation market size, reaching $3.33 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%.
Various factors contributing to this growth during the projected period include government efforts to enhance cancer care, increased public awareness of early diagnosis and therapy, improved disposable income, heightened emphasis on precision medicine, and the growing demand for targeted cancer treatments. Major trends happening during this forecast period consist of the incorporation of artificial intelligence into radiation therapy, online adaptive radiotherapy, the rising popularity of hypo fractionated radiation therapy, the use of proton therapy for accurate cancer treatment, and moving towards image-guided radiation therapy (IGRT).
What Main Forces Are Fueling Expansion In The Medical Irradiation Market?
The rising instances of cancer are set to boost the expansion of the medical irradiation market in the future. Cancer, characterized by unregulated cell growth, impacts various organs, leading to considerable morbidity and mortality globally. Medical irradiation, an essential cancer treatment method, leverages targeted radiation to harm or eliminate cancer cells while reducing the impact on healthy tissues. For example, a study by the Leukemia & Lymphoma Society, a US non-profit health organization, projected that in 2023, 184,720 individuals in the US will be diagnosed with leukemia, lymphoma, or myeloma. Also, around 1,958,310 new cancer diagnoses are anticipated in the country in 2023, with leukemia, lymphoma, and myeloma accounting for 9.4% of these cases. Hence, the rising cancer prevalence is fuelling the expansion of the medical irradiation market.
What Are The Primary Segments In The Global Medical Irradiation Market?
The medical irradiation market covered in this report is segmented –
1) By Disease Type: Trisomy 21, Translocation Medical Irradiation, Mosaic Medical Irradiation
2) By Treatment: Diagnosis, Therapy
3) By Distribution Channel: Direct Tender, Retail Sales, Other Distribution Channels
4) By End User: Hospital, Clinics, Homecare Setting, Therapy Centers, Other End-Users
Subsegments:
1) By Trisomy 21: Prenatal Diagnosis, Postnatal Diagnosis
2) By Translocation Medical Irradiation: Acute Lymphoblastic Leukemia (ALL), Chronic Myeloid Leukemia (CML)
3) By Mosaic Medical Irradiation: Genetic Counseling, Diagnostic Imaging
Pre-Book The Medical Irradiation Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Medical Irradiation Market?
Leading organizations in the medical irradiation market are striving to outperform their competitors by introducing creative solutions like the Premium Dual-Energy Mobile System. This high-grade medical imaging device employs dual-energy technology to improve diagnostic capabilities and can be transported across different clinical environments, delivering frontline imaging solutions. For example, KA Imaging, a manufacturing company based in Canada, launched its Reveal Mobi Pro dual-energy mobile X-ray system in July 2023. The system is a all-in-one mobile X-ray solution, incorporating SpectralDR technology with KA Imaging's Reveal 35C detector. The ability to produce dual-energy and traditional images at the same time, using a single exposure at the patient's bedside, not only enhances patient and hospital outcomes, but also protects revenue by reducing expenses.
Who Are the Key Players In The Medical Irradiation Market?
Major companies operating in the medical irradiation market are:
• Hitachi Ltd.
• Thermo Fisher Scientific Inc.
• Toshiba Corporation
• Siemens Healthcare GmbH
• Koninklijke Philips N.V.
• GE Healthcare Company
• Mayo Clinic Health System
• Canon Medical Systems R&D (Dalian) Co. Ltd.
• PerkinElmer Inc.
• Varian Medical Systems Inc.
• Elekta AB
• Accuray Incorporated
• Ion Beam Applications S.A.
• Brainlab AG
• ViewRay Technologies Inc.
• Mevion Medical Systems Inc.
• RaySearch Laboratories AB
• NTP Radioisotopes SOC Ltd.
• RefleXion Medical Inc.
• Vision RT Ltd.
• Sun Nuclear Corporation
• IZI Medical Products LLC
• Eckert & Ziegler BEBIG GmbH
• C-RAD AB
• Panacea Medical Technologies Pvt. Ltd.
• Standard Imaging Inc.
• CIVCO Radiotherapy Inc.
• IntraOp Medical Corporation
• RTsafe Solutions Ltd.
• ASG Superconductors S.p.A.
• Mirada Medical Corporation
What Is The Most Dominant Region In The Medical Irradiation Market?
North America was the largest region in the medical irradiation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical irradiation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
